Skip to content
PeptideSorted

The week in peptides, sorted in five minutes.

The week's peptide and GLP-1 news in five minutes: FDA moves, new studies explained, and price changes. Free, every Tuesday morning, written to the same sourcing and medical-review rules as the site.

Peptide news, sorted. Plus the printable dose chart.

Sorted, every Tuesday: the week's peptide and GLP-1 news in five minutes: FDA moves, new studies explained, and price changes. Subscribe and the one-page dose and injection-site chart arrives first.

  • FDA and legal changes, with the notice linked
  • Three new studies, each with its main limitation
  • GLP-1 cash price moves

Double opt-in. One click to unsubscribe. No dosing advice by email.

What is in every issue

Same order every week, so you can skip straight to the part you care about.

  1. 1The one thingThe week's biggest story in about 120 words, with the source.
  2. 2FDA and legal trackerWhat changed at the FDA or in the courts, linked to the notice itself.
  3. 3Three studies, sortedPubMed ID, what was studied, what it found, and the main limitation.
  4. 4Price watchCash prices for brand and compounded GLP-1s, dated, with the source.
  5. 5Reader questionOne question from a reader, answered and checked by our medical reviewer.
  6. 6Tool of the weekOne calculator or chart worth knowing, with a worked example.
  7. 7One labeled sponsorAt most one, always marked "Sponsored", never inside the editorial sections.

Archive

Issue #1 goes out on the first Tuesday after launch. Every issue is published here as a normal web page, linked to the guides it mentions, so you can read back without subscribing.